IQ4I Research & consultancy's report on Nuclear medicine global market forecast to 2020

O

2014

IQ4I Research & Consultancy Pvt. Ltd.

[email protected]

www.iq4i.com

Nuclear Medicine/Radiopharmaceuticals Global Market

[End Users (Hospitals, Diagnostic Centers, Academic Research Laboratories & Industries)], Diagnostic Type [SPECT (Technetium (Tc-99m), Gallium (Ga-67), Iodine (I-123), Thallium (Tl-201), Yttrium (Y-90) and Others), PET (Fluorodeoxyglucose (18f-FDG), Rubidium (Rb-82), Gallium (Ga-68) and Others)] & Applications (Oncology, Cardiology, Neurology, Nephrology, and Others)], Therapeutic (Beta-Radiation, Alpha-Radiation and Brachytherapy)]

– Forecast to 2020

Copyright © 2014 IQ4I

All Rights Reserved. This document contains highly confidential

information and is the sole property of IQ4I. No part of it may be

circulated, copied, quoted, or otherwise reproduced without the

approval of IQ4I.



–Forecast to 2020



–Forecast to 2020

1.1 REPORT DESCRIPTION

Nuclear medicine global market is estimated to be $5,500 million in 2013 and is expected to

grow at a CAGR of 5.6% to reach $8,050 million by 2020. Nuclear medicinal market is mainly

classified into type (diagnosis & therapeutics), application and end-users. The global market by

diagnosis is further divided into SPECT and PET while therapeutics market is segmented into

alpha, beta and brachytherapy. Diagnosis is the largest segment, accounting for 88.6% of global

market share in 2013.

Increase in therapeutic application, public awareness, use of hybrid imaging, technological

advancements, cyclotron production of radiopharmaceuticals, efficient diagnosis and

treatments, emerging radioisotopes and replacement of traditional equipment are factors or

opportunities expected to drive the nuclear medicine market. However, stringent regulatory

issues, supply shortage, radio toxicity, high cost and huge investment are factors hindering the

market growth during the forecasted period.

North America holds the largest share for nuclear medicine market, followed by Europe.

Asia-Pacific (APAC) and Rest of the World are poised to grow at a CAGR % by 2014. This

region growth is attributed to aging population, rise in public awareness

Countries like China, India, Australia, and Brazil will be major contributors to the growth of the

market.

Some of the key players contributing at a global level for nuclear medicine market growth are

Cardinal Health, Inc. (United States), Cambridge Isotope Laboratories (United States), GE

Healthcare (United Kingdom), IBA Group (Belgium) and Lantheus Medical Imaging, Inc. (United

Sates).



–Forecast to 2020

1.2 MARKET SEGMENTATION

FIGURE 1

NUCLEAR MEDICINE MARKET: MARKET SEGMENTATION

Source: Annual/Financial Reports, SEC Filings, Investor/Corporate presentations, Society of Nuclear Medicine and

Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), Nuclear Medicine Associations and

Journals, WHO, EANM, JNM, Industry

Hospitals

Global Nuclear Medicine Market

Nuclear MedicineBy End Users

Nuclear MedicineBy Type

Stable IsotopesBy Isotopes

Market by Geography

Diagnostic Centers

Academic Research Lab’s

Industries

C-13

D2

O-18

N-15

S-32

Others

North America

Europe

Asia -Pacific

Rest of the World

Diagnostics

Ga-67

Therapeutics

Beta Radiation Therapy

BrachytherapyI-123

Re-186

Tc-99m

Tl-201

Y-90

Others

18f-FDG

Rb-82

Ga-68

SPECT PET

Others



–Forecast to 2020

Disclaimer: IQ4I strategic analysis services are limited publications containing valuable market

information provided to a select group of customers in response to orders. Our customers

acknowledge, when ordering, that IQ4I strategic analysis services are for our customers’

internal use and not for general publication or disclosure to third parties. Quantitative market

information is based primarily on interviews and therefore, is subject to fluctuation.

IQ4I does not endorse any vendor, product or service depicted in its research publications. IQ4I

strategic analysis publications consist of the opinions of IQ4I' research and should not be

construed as statements of fact. IQ4I disclaims all warranties, expressed or implied, with

respect to this research, including any warranties of merchantability or fitness for a particular

purpose.

IQ4I takes no responsibility for any incorrect information supplied to us by manufacturers or

users.

All trademarks, copyrights and other forms of intellectual property belong to their respective

owners and may be protected by copyright. Under no circumstance may any of these be

reproduced in any form without the prior written agreement of their owner.

No part of this strategic analysis service may be given, lent, resold or disclosed to non-

customers without written permission.

Reproduction and/or transmission in any form and by any means including photocopying,

mechanical, electronic, recording or otherwise, without the permission of the publisher is

prohibited.

For information regarding permission, contact:

Tel: +91 80 60500229

Email: [email protected]

mailto:[email protected]

IQ4I Research & consultancy's report on Nuclear medicine global market forecast to 2020

Health & Medicine

Transcript of IQ4I Research & consultancy's report on Nuclear medicine global market forecast to 2020